Julian is an integrative physiologist translating novel findings from animal models to humans. He was educated at the University of Birmingham (BSc (Hons) 1984) and University of London (PhD, 1987). Subsequently, between 1989-1994, he was a fellow at EI DuPont, Wilmington and University Washington, Seattle, US, and an Alexander von Humboldt Fellow (University of Göttingen, Germany). In 1994, he was awarded a British Heart Foundation Fellowship at the University of Bristol, UK. In 2017, he transferred to the University of Auckland, New Zealand, where he is Director of Manaaki Manawa (established 2019) – the Centre of Heart Research, and Co-Director of Pūtahi Manawa – Healthy Hearts of Aotearoa New Zealand (established 2021), which is the first national Centre of Research Excellence addressing equity in heart health through community-led research. His research focuses on the neural coupling between the cardiovascular and respiratory systems. His novel fundamental discoveries have resulted in first-in-human trials for treating neurogenic hypertension, sleep apnoea and heart failure. He is founder member and Chief Scientific Officer for Ceryx Medical Ltd. designing a novel bionic pacemaker for heart failure. He has 445 publications, ~24,600 citations and an h-index of 84. He was made Fellow of the Royal Society of New Zealand in 2021.

Andrew is currently a trainee in the MD-PhD Clinician Scientist Training Program at the Faculty of Medicine, University of Queensland. He completed his MASc in Tissue and Biomedical Engineering (2021) at the University of Toronto and the McEwen Stem Cell Institute, where he studied cardiac cell therapeutics, and applying them in preclinical transplantation models. For his PhD, he's currently working on developing bioengineered, surgical approaches for congenital and adult heart repair with Prof. James Hudson, Prof. Enzo Porrello, and Dr. Christian Brizard.

Dr Bayat is a cardiologist sub-specialised in advanced heart failure, cardiac transplant and mechanical circulatory support, currently working as a consultant cardiologist with the Advanced Heart Failure and Cardiac Transplant Unit at The Prince Charles Hospital, Brisbane. she is also a PhD candidate at The University of Queensland, researching novel strategies for the management of patients with heart failure.

Dr Nicholas Doumtsis is a current Basic Physician Trainee at Austin Health and Clinic Tutor at the University of Melbourne. His current research interests include the investigation of novel biomarkers in Cardiovascular disease, aswell as study of the alternate arm of the Renin Angiotensin Aldosterone system, with a focus on Angiotensin-Converting Enzyme 2.

Currently an early career scientist in the Heart Failure Research Group headed by Professor David Kaye. I was awarded my PhD in 2021 from Monash University, where I investigated the role of sphingolipids in cardiac remodeling under the guidance of Associate Professor Bing Wang and Professor Bernard Flynn. My current research focuses on developing clinically relevant animal models for heart failure with preserved ejection (HFpEF) to investigate disease mechanisms and therapeutic targets for HFpEF.

Professor David Kaye is Director of the Department of Cardiology at the Alfred Hospital and a senior member of the Advanced Heart Failure Service. He also leads the Cardiology Research Program at the Baker Heart and Diabetes Institute. Professor Kaye’s studies have centred around the progressive nature of heart failure and has identified a range of its fundamental contributing mechanisms. To this end his research work has been directed towards the development of improved approaches for the care of heart failure patients.